Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05639569 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 145 to confirmed 147
    • Study sites: 8 to 15
    v9
  2. Study description expanded, about 81 wordsv8
  3. Primary completion date: Dec 30, 2024 to Dec 30, 2026v7 Show 5 more changesShow less
    • Start date: Dec 26, 2022 to May 3, 2023
    • Study sites: 9 to 8
    • Study completion date: Dec 30, 2027 to Dec 30, 2030
    • Interventions: Ankura™ TAA Stent Graft Systems (Device) to Ankura™ TAA Stent Graft System (Device)
    • Study description shortened, about 17 words
  4. Study sites: 8 to 9v6
  5. Site details revised at 1 of 8 sitesv5
Show 3 earlier versionsHide 3 earlier versions
  1. Study sites: 7 to 8v4
  2. Study sites: 8 to 7v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 30, 2022 to Dec 26, 2022
    • Site details revised at 8 of 8 sites
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to collect clinical data on patient outcomes, evaluate the safety and performance of Ankura TAA Stent Graft System and Surpass Super Stiff Guidewire, and build clinical evidence for patients with Descending Thoracic Aneurysm (DTA) or Type B Aortic Dissection (TBAD).
Trial Details
NCT Number NCT05639569
Lead Sponsor Lifetech Scientific (Shenzhen) Co., Ltd.
Conditions
(from sponsor)		 Aneurysm Thoracic, Dissection of Thoracic Aorta
Related terms Aortic Aneurysm, Thoracic, Dissection, Thoracic Aorta
Enrollment 147 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov